BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26607777)

  • 1. Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer.
    Kemik P; Saatli B; Yıldırım N; Kemik VD; Deveci B; Terek MC; Koçtürk S; Koyuncuoğlu M; Saygılı U
    Gynecol Oncol; 2016 Jan; 140(1):64-9. PubMed ID: 26607777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.
    Diefenbach CS; Shah Z; Iasonos A; Barakat RR; Levine DA; Aghajanian C; Sabbatini P; Hensley ML; Konner J; Tew W; Spriggs D; Fleisher M; Thaler H; Dupont J
    Gynecol Oncol; 2007 Feb; 104(2):435-42. PubMed ID: 17023034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic and prognostic value of serum YKL-40 in endometrial cancer.
    Fan JT; Si XH; Liao Y; Shen P
    Arch Gynecol Obstet; 2013 Jan; 287(1):111-5. PubMed ID: 22945838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative serum levels of YKL 40 and CA125 as a prognostic indicators in patients with endometrial cancer.
    Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Wagrodzki M; Kowalska M
    Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():141-147. PubMed ID: 28624692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
    Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL
    Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.
    Abbink K; Zusterzeel PL; Geurts-Moespot AJ; Herwaarden AEV; Pijnenborg JM; Sweep FC; Massuger LF
    Tumour Biol; 2018 Feb; 40(2):1010428318757103. PubMed ID: 29463191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging.
    Minar L; Klabenesova I; Jandakova E; Zlamal F; Bienertova-Vasku J
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1644-52. PubMed ID: 26223178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.
    Chudecka-Głaz AM; Cymbaluk-Płoska AA; Menkiszak JL; Sompolska-Rzechuła AM; Tołoczko-Grabarek AI; Rzepka-Górska IA
    J Ovarian Res; 2014; 7():62. PubMed ID: 25018782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
    Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
    Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
    Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
    Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection and prognosis of ovarian cancer using serum YKL-40.
    Dupont J; Tanwar MK; Thaler HT; Fleisher M; Kauff N; Hensley ML; Sabbatini P; Anderson S; Aghajanian C; Holland EC; Spriggs DR
    J Clin Oncol; 2004 Aug; 22(16):3330-9. PubMed ID: 15310777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management.
    Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S
    Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HE4 is an independent prognostic marker in endometrial cancer patients.
    Mutz-Dehbalaie I; Egle D; Fessler S; Hubalek M; Fiegl H; Marth C; Widschwendter A
    Gynecol Oncol; 2012 Aug; 126(2):186-91. PubMed ID: 22525819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.
    Stiekema A; Lok C; Korse CM; van Driel WJ; van der Noort V; Kenter GG; Van de Vijver KK
    Virchows Arch; 2017 Jun; 470(6):655-664. PubMed ID: 28401338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum apelin and YKL-40 levels in early and late-onset pre-eclampsia.
    Kucur M; Tuten A; Oncul M; Acikgoz AS; Yuksel MA; Imamoglu M; Balci Ekmekci O; Yilmaz N; Madazli R
    Hypertens Pregnancy; 2014 Nov; 33(4):467-75. PubMed ID: 25068525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Serum Human Epididymis Protein 4 Levels in Early Stage Endometrial Cancer: A Prospective Study.
    Fanfani F; Restaino S; Cicogna S; Petrillo M; Montico M; Perrone E; Radillo O; De Leo R; Ceccarello M; Scambia G; Ricci G
    Int J Gynecol Cancer; 2017 Jul; 27(6):1200-1205. PubMed ID: 28557834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
    Bian J; Sun X; Li B; Ming L
    Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and tissue level of YKL-40 in endometrial cancer.
    Fan JT; Li MJ; Shen P; Xu H; Li DH; Yan HQ
    Eur J Gynaecol Oncol; 2014; 35(3):304-8. PubMed ID: 24984547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum HE4 as a prognostic marker in endometrial cancer--a population based study.
    Brennan DJ; Hackethal A; Metcalf AM; Coward J; Ferguson K; Oehler MK; Quinn MA; Janda M; Leung Y; Freemantle M; ; Webb PM; Spurdle AB; Obermair A
    Gynecol Oncol; 2014 Jan; 132(1):159-65. PubMed ID: 24211402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer.
    Johansen JS; Christensen IJ; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Brünner N; Nielsen HJ
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):621-6. PubMed ID: 25597749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.